{"id":"https://openalex.org/W1965718249","doi":"https://doi.org/10.2174/138945012799499794","title":"Ladostigil: A Novel Multimodal Neuroprotective Drug with Cholinesterase and Brain-Selective Monoamine Oxidase Inhibitory Activities for Alzheimers Disease Treatment","display_name":"Ladostigil: A Novel Multimodal Neuroprotective Drug with Cholinesterase and Brain-Selective Monoamine Oxidase Inhibitory Activities for Alzheimers Disease Treatment","alternate_titles":[],"publication_year":2012,"publication_date":"2012-02-27","ids":{"openalex":"https://openalex.org/W1965718249","doi":"https://doi.org/10.2174/138945012799499794","mag":"1965718249","pmid":"https://pubmed.ncbi.nlm.nih.gov/22280345"},"language":"en","primary_location":{"id":"doi:10.2174/138945012799499794","doi":"https://doi.org/10.2174/138945012799499794","is_oa":false,"landing_page_url":"https://doi.org/10.2174/138945012799499794","pdf_url":null,"source":{"id":"https://openalex.org/S140884253","display_name":"Current Drug Targets","issn_l":"1389-4501","issn":["1389-4501","1873-5592"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Drug Targets","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1965718249"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082642183","display_name":"Orly Weinreb","orcid":"https://orcid.org/0000-0003-1405-9612","observed_orcids":["https://orcid.org/0000-0003-1405-9612","https://orcid.org/0009-0006-6153-8914"]},"institutions":[{"id":"https://openalex.org/I174306211","display_name":"Technion \u2013 Israel Institute of Technology","ror":"https://ror.org/03qryx823","country_code":"IL","type":"education","lineage":["https://openalex.org/I174306211"]},{"id":"https://openalex.org/I4210117163","display_name":"Rappaport Family Institute for Research in the Medical Sciences","ror":"https://ror.org/029hzjx43","country_code":"IL","type":"facility","lineage":["https://openalex.org/I4210117163"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Orly Weinreb","raw_affiliation_strings":["Department of Pharmacology, Rappaport Family Research Institute, Haifa, Israel. worly@tx.technion.ac.il"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Rappaport Family Research Institute, Haifa, Israel. worly@tx.technion.ac.il","institution_ids":["https://openalex.org/I174306211","https://openalex.org/I4210117163"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005030965","display_name":"Tamar Amit","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tamar Amit","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000909905","display_name":"Orit Bar\u2010Am","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Orit Bar-Am","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5053858269","display_name":"Moussa B. H. Youdim","orcid":"https://orcid.org/0000-0002-1361-3872","observed_orcids":["https://orcid.org/0000-0002-1361-3872"]},"institutions":[{"id":"https://openalex.org/I174306211","display_name":"Technion \u2013 Israel Institute of Technology","ror":"https://ror.org/03qryx823","country_code":"IL","type":"education","lineage":["https://openalex.org/I174306211"]}],"countries":["IL"],"is_corresponding":true,"raw_author_name":"Moussa B.H. Youdim","raw_affiliation_strings":["Department of Pharmacology, Technion- Faculty of Medicine, P.O.B. 9697, 31096 Haifa, Israel.,Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Technion- Faculty of Medicine, P.O.B. 9697, 31096 Haifa, Israel.,Israel","institution_ids":["https://openalex.org/I174306211"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5053858269"],"corresponding_institution_ids":["https://openalex.org/I174306211"],"apc_list":null,"apc_paid":null,"fwci":7.7999,"has_fulltext":false,"cited_by_count":164,"citation_normalized_percentile":{"value":0.98146226,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":100},"biblio":{"volume":"13","issue":"4","first_page":"483","last_page":"494"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.9404000043869019,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.9404000043869019,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.056699998676776886,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.8679999709129333},{"id":"https://openalex.org/keywords/lewy-body-disease","display_name":"Lewy body disease","score":0.7699999809265137},{"id":"https://openalex.org/keywords/acetylcholinesterase-inhibition","display_name":"acetylcholinesterase inhibition","score":0.8100000023841858},{"id":"https://openalex.org/keywords/butyrylcholinesterase-inhibition","display_name":"butyrylcholinesterase inhibition","score":0.9769999980926514},{"id":"https://openalex.org/keywords/monoamine-oxidase-a-inhibition","display_name":"monoamine oxidase A inhibition","score":0.6309999823570251},{"id":"https://openalex.org/keywords/monoamine-oxidase-b-inhibition","display_name":"monoamine oxidase B inhibition","score":0.9380000233650208},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.9449999928474426},{"id":"https://openalex.org/keywords/app-processing","display_name":"APP processing","score":0.7730000019073486},{"id":"https://openalex.org/keywords/protein-kinase-c-signaling","display_name":"protein kinase C signaling","score":0.8410000205039978},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.9470000267028809},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.5799999833106995},{"id":"https://openalex.org/keywords/gliosis","display_name":"gliosis","score":0.7490000128746033},{"id":"https://openalex.org/keywords/global-cerebral-ischemia","display_name":"global cerebral ischemia","score":0.6430000066757202},{"id":"https://openalex.org/keywords/closed-head-injury","display_name":"closed head injury","score":0.8159999847412109},{"id":"https://openalex.org/keywords/cerebral-edema","display_name":"cerebral edema","score":0.828000009059906},{"id":"https://openalex.org/keywords/scopolamine-induced-amnesia","display_name":"scopolamine-induced amnesia","score":0.7850000262260437},{"id":"https://openalex.org/keywords/antidepressant-safety","display_name":"antidepressant safety","score":0.6480000019073486},{"id":"https://openalex.org/keywords/neurotrophic-factors","display_name":"neurotrophic factors","score":0.621999979019165},{"id":"https://openalex.org/keywords/mitochondrial-membrane-potential","display_name":"mitochondrial membrane potential","score":0.7929999828338623}],"concepts":[{"id":"https://openalex.org/C2776024655","wikidata":"https://www.wikidata.org/wiki/Q410867","display_name":"Monoamine oxidase","level":3,"score":0.8145520687103271},{"id":"https://openalex.org/C31896038","wikidata":"https://www.wikidata.org/wiki/Q415635","display_name":"Cholinesterase","level":2,"score":0.7777048349380493},{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.7168591618537903},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.6395047903060913},{"id":"https://openalex.org/C187714386","wikidata":"https://www.wikidata.org/wiki/Q420225","display_name":"Monoamine neurotransmitter","level":4,"score":0.5830888152122498},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5522255897521973},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5216365456581116},{"id":"https://openalex.org/C17077164","wikidata":"https://www.wikidata.org/wiki/Q1185869","display_name":"Inhibitory postsynaptic potential","level":2,"score":0.5215456485748291},{"id":"https://openalex.org/C39398028","wikidata":"https://www.wikidata.org/wiki/Q18028862","display_name":"Monoamine oxidase B","level":4,"score":0.48596298694610596},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.46469470858573914},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.45048192143440247},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.3712312579154968},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2873592972755432},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22181639075279236},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.20098525285720825},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1655634641647339},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.14313480257987976},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.06861808896064758},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.04815882444381714}],"mesh":[{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007189","descriptor_name":"Indans","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007189","descriptor_name":"Indans","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007189","descriptor_name":"Indans","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008996","descriptor_name":"Monoamine Oxidase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008996","descriptor_name":"Monoamine Oxidase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008996","descriptor_name":"Monoamine Oxidase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D020961","descriptor_name":"Lewy Body Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D020961","descriptor_name":"Lewy Body Disease","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/138945012799499794","doi":"https://doi.org/10.2174/138945012799499794","is_oa":false,"landing_page_url":"https://doi.org/10.2174/138945012799499794","pdf_url":null,"source":{"id":"https://openalex.org/S140884253","display_name":"Current Drug Targets","issn_l":"1389-4501","issn":["1389-4501","1873-5592"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Drug Targets","raw_type":"journal-article"},{"id":"pmid:22280345","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22280345","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current drug targets","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320308970","display_name":"Teva Pharmaceutical Industries","ror":"https://ror.org/01wfv3m53"},{"id":"https://openalex.org/F4320323721","display_name":"Technion-Israel Institute of Technology","ror":"https://ror.org/03qryx823"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W156009051","https://openalex.org/W68465221","https://openalex.org/W2022533311","https://openalex.org/W2052409352","https://openalex.org/W2011514670","https://openalex.org/W2157678497","https://openalex.org/W1970016371","https://openalex.org/W2161809622","https://openalex.org/W2081208063","https://openalex.org/W2019684651"],"abstract_inverted_index":{"Ladostigil":[0,81,127],"[(N-propargyl-(3R)":[1],"aminoindan-5yl)-ethyl":[2],"methyl":[3],"carbamate]":[4],"is":[5],"a":[6,47,60,72,218],"dual":[7],"acetylcholine-butyrylcholineesterase":[8],"and":[9,15,30,43,107,110,116,134,139,154,179,198,203,221,249,253],"brain":[10,100],"selective":[11],"monoamine":[12],"oxidase":[13],"(MAO)-A":[14],"-B":[16],"inhibitor":[17],"in":[18,27,46,88,98,114,125,137,140,152,158,194,247,264],"vivo":[19],"(with":[20],"little":[21],"or":[22],"no":[23],"MAO":[24],"inhibitory":[25],"effect":[26],"the":[28,35,55,64,112,192,210,226,237,241,254,265,269],"liver":[29],"small":[31],"intestine),":[32],"intended":[33],"for":[34,240],"treatment":[36],"of":[37,63,123,169,175,186,191,200,213,229,245,268],"dementia":[38],"co-morbid":[39],"with":[40],"extrapyramidal":[41],"disorders":[42],"depression":[44],"(presently":[45],"Phase":[48],"IIb":[49],"clinical":[50],"study).":[51],"This":[52,233],"suggests":[53],"that":[54,92,209,258],"drug":[56],"should":[57],"not":[58],"cause":[59,95],"significant":[61,96],"potentiation":[62],"cardiovascular":[65],"response":[66],"to":[67,84,130,225,261],"tyramine,":[68],"thereby":[69],"making":[70],"it":[71,93],"potentially":[73],"safer":[74],"antidepressant":[75],"than":[76],"other":[77],"irreversible":[78],"MAO-A":[79],"inhibitors.":[80],"was":[82,128],"shown":[83],"antagonize":[85],"scopolamine-induced":[86],"impairment":[87],"spatial":[89,117],"memory,":[90],"indicating":[91],"can":[94],"increases":[97],"rat":[99,143],"cholinergic":[101],"activity.":[102,205],"Furthermore,":[103],"ladostigil":[104,246],"prevented":[105],"gliosis":[106],"oxidative-nitrative":[108],"stress":[109],"reduced":[111],"deficits":[113],"episodic":[115],"memory":[118],"induced":[119,148,157],"by":[120,149,160],"intracerebroventricular":[121],"injection":[122],"streptozotocin":[124],"rats.":[126],"demonstrated":[129,208],"possess":[131],"potent":[132],"anti-apoptotic":[133],"neuroprotective":[135,165,219],"activities":[136,166,267],"vitro":[138],"various":[141],"neurodegenerative":[142],"models,":[144],"(e.g.":[145],"hippocampal":[146],"damage":[147],"global":[150],"ischemia":[151],"gerbils":[153],"cerebral":[155],"oedema":[156],"mice":[159],"closed":[161],"head":[162],"injury).":[163],"These":[164],"involve":[167],"regulation":[168],"amyloid":[170],"precursor":[171],"protein":[172,176,181],"processing;":[173],"activation":[174],"kinase":[177,182],"C":[178],"mitogen-activated":[180],"signaling":[183,256],"pathways;":[184],"inhibition":[185],"neuronal":[187],"death":[188],"markers;":[189],"prevention":[190],"fall":[193],"mitochondrial":[195],"membrane":[196],"potential":[197,243],"upregulation":[199],"neurotrophic":[201],"factors":[202],"antioxidative":[204],"Recent":[206],"findings":[207],"major":[211],"metabolite":[212],"ladostigil,":[214],"hydroxy-1-(R)-aminoindan":[215],"has":[216],"also":[217],"activity":[220,228],"thus,":[222],"may":[223],"contribute":[224],"overt":[227],"its":[230],"parent":[231],"compound.":[232],"review":[234],"will":[235],"discuss":[236],"scientific":[238],"evidence":[239],"therapeutic":[242],"use":[244],"Alzheimer's":[248],"Lewy":[250],"Body":[251],"diseases":[252],"molecular":[255],"pathways":[257],"are":[259],"considered":[260],"be":[262],"involved":[263],"biological":[266],"drug.":[270]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1965718249","counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":17},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":13},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":19},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":13},{"year":2013,"cited_by_count":15},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
